-
April 6, 2019
EMA released the guideline on the non-clinical requirements for radiopharmaceuticals
The European Medicine Agency (EMA) has issued the guideline on the non-clinical requirements for the radiopharmaceuticals. The…
Read More -
April 4, 2019
Import and Release of US-Labelled Choletec (Mebrofenin)
Choletec Canadian product has been unavailable in Canada and US labeled supply was allowed in by Health Canada to bridge in October 2018. Currently, the product is backordered due to logistical…
Read More -
January 21, 2019
Cessation of Mo-99 Production Activities by NTP Radioisotopes Ltd. (NTP) Update ANSTO Press Release – OPAL reactor – Update
The AIPES Security of Supply working Group (SoS WG) composed of Mo-99 processors, research reactors…
Read More -
October 22, 2018
Import and Release of US-Labelled Choletec (Mebrofenin)
Recently, Health Canada received a proposal from Bracco Imaging Canada to import and release US-labelled Choletec (Mebrofenin) into Canada in order to mitigate a shortage…
Read More -
December 5, 2017
Administration of quality assurance systems in Canadian Radiopharmacy
In response to a growing concern from our membership regarding the administration of quality assurance systems in Canadian Radiopharmacy, the Canadian Association…
Read More -
January 18, 2017
Health Canada Notice to Stakeholders
Release of Guidance Documents for Consultation: Various good manufacturing practices and drug establishment licensing guidance documents…
Read More
Join us as a member
Filled out our membership form and join CARS Membership today for more radiopharmaceutical and scientific knowledge.